Investments, Funding & Disinvestment

Located at El Nasr Mall on Ahmed Oraby Street, the clinic houses more than 20 specialized clinics staffed by experienced medical consultants.

The acquisition will give Lilly access to Merida’s technology for developing biologics that selectively eliminate disease-causing autoantibodies.

Under the agreement, Teva would acquire worldwide rights to Igalmi (dexmedetomidine) sublingual film, a prescription medicine, as well as BXCL501, an investigational therapy.

The new site will complement RayzeBio’s existing 77,000-square-foot radiopharmaceutical manufacturing facility in Indianapolis, located about 20 miles southwest of Whitestown.

The framework calls on countries to maintain high-quality disease surveillance, preserve laboratory and emergency response capacity, strengthen routine immunization and secure sustainable domestic financing.

These therapies can require multiple stages, including DNA starting materials, RNA production, targeted delivery technologies, formulation, analytical testing and scalable drug product manufacturing.

The Center provides round-the-clock support to healthcare facilities across Moscow and analyzes more than 180,000 computed tomography (CT), magnetic resonance imaging (MRI), mammography and X-ray examinations every week.

Under the partnership, M42 will support Botswana’s efforts to transform its healthcare system through digital health, genomics, precision medicine and workforce development.

The two firms launched Metsera in 2022, and the biotech emerged from stealth in 2024 after securing US$290 million in financing.

The antisense oligonucleotide (ASO) medicine, which GSK will market in Japan as Hibsago, is approved for adults with hepatitis B who meet specified viral markers.